External site

By following this link, you are leaving Medically and entering a website that is not owned or controlled by Roche. Roche does not take any responsibility for access to or use of this website, nor for any content therein.

Leave site
Home EURETINA 2020
Roche and Genentech at

EURETINA 2020

October 02 - October 04
Amsterdam, Netherlands
euretina.org
Add to calendar
Share feedback
Share page
-
Medical Materials
Agenda
Highlights
Coming soon
09:00 AM
Duration 4mins Virtual
Development of geographic atrophy assessed by multimodal imaging in intermediate age-related macular degeneration
Schmitz-Valckenberg S
Ophthalmology

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
Duration 4mins Virtual
New Data in a Mouse Model of Spontaneous Choroidal Neovascularization Support the Role of Ang-2 Inhibition in Driving Sustained Vascular Stabilization and Reduced Fibrosis Progression
Canonica J
Ophthalmology

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
Duration 4mins Virtual
Pharmacokinetic Profile of the Port Delivery System with Ranibizumab (PDS) in the Phase 2 Ladder Trial
Khanani A
Ophthalmology

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
Duration 4mins Virtual
Prediction of ranibizumab injection frequency in patients with macular edema due to retinal vein occlusion during as need dosing period of BRAVO and CRUISE Phase 3 trials
Steffen V
Ophthalmology

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
Duration 4mins Virtual
Real-world Outcomes of Current Treatment Options for Diabetic Macular Edema: A Systematic Literature Review
Bandello F
Ophthalmology

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
Duration 4mins Virtual
Use of machine learning on Initial lesion growth rates and other baseline prognostic factors to improve the design of clinical trials in Geographic Atrophy (GA)
Friesenhahn M
Ophthalmology

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
08:30 AM
Duration 5mins Virtual
Long-acting Drug Delivery in nAMD: Archway Phase 3 Results
Regillo C
Ophthalmology

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
09:00 AM
Duration 4mins Virtual
Optimization of the Implant Insertion Procedure for the Port Delivery System With Ranibizumab (PDS) in the Ladder Phase 2 Trial
Mittra, R
Ophthalmology

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
Duration 4mins Virtual
STAIRWAY: Impact of Faricimab Treatment on Neovascular Age-Related Macular Degeneration (nAMD) Lesions Using Different Imaging Modalities
Michels S
Ophthalmology

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
Duration 4mins Virtual
Anatomical, Visual, and Durability Outcomes From the BOULEVARD Phase 2 Trial of Faricimab for Diabetic Macular Edema
Eter N
Ophthalmology

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar

Sign up or login to unlock the full suite of MEDICALLY features
EURETINA 2020: In-Depth Report
Springer Healthcare
Open asset

This website is intended for healthcare professionals outside the United Kingdom (UK) and Australia. Registration status and prescribing information of medicinal products may differ between countries. Please refer to local product information for any medicinal products mentioned on this website.